Skip to main content
. 2025 Mar 3;10(3):e20240087. doi: 10.1530/EOR-24-0087

Table 2.

Treatment of NB due to lumbar spine diseases.

Category Method
Conservation treatment Bladder reflex trigger, behavioral training, penis sleeves and external urinary collectors, and modifying drinking habits
Drug therapy
 Anticholinergics Darifenacin, fesoterodine, oxybutynin, propiverine, solifenacin, tolterodine and trospium chloride
 β3 adrenergic receptor agonists Mirabegron and vibegron
 Alpha-adrenergic antagonists Tamsulosin and terazosin
 Intracavitary perfusion therapy Oxybutynin, capsaicin and its analogs and local anesthetic buprocaine hydrochloride
 Others Desmopressin, potassium channel opener and neurokinin receptor antagonist
Urethral catheterization treatment Clean intermittent catheterization, indwelling urethral catheters, suprapubic catheters and external condom catheters
Surgical treatment
 Procedures to expand bladder capacity Botulinum toxin bladder wall injection/bladder chemoprotection and bladder dilation
 Procedures to increase urethral control Artificial urethral sphincter implantation, periurethral filler injection, urethral sling and femoral thin muscle urethral myoplasty
 Modalities to manage voiding disorders Neuromodulation, external urethral sphincterotomy and CUD

NB, neurogenic bladder; CUD, continuous urinary diversion.